Skip to content

Clinical trials

Phase 4 Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: United States Clear all

179 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20025
20036
200413
200511
200610
20075
200822
200923
201012
201111
20127
20134
20143
20152
20163
20174
20184
20194
20202
20214
20226
20235
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed129
Terminated19
Withdrawn11
Recruiting10
Unknown status9
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis21
Daiichi Sankyo10
Novartis Pharmaceuticals9
Boehringer Ingelheim8
Forest Laboratories8
University of Florida8
Brigham and Women's Hospital6
University of Texas Southwestern Medical Center5
Johns Hopkins University4
Creighton University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension179
Diabetes Mellitus, Type 218
Diabetes Mellitus17
Cardiovascular Diseases11
Metabolic Syndrome9
Coronary Artery Disease7
Pre-Eclampsia7
Obesity6
Prehypertension6
Dyslipidemias5

Trials

Showing 1 to 25 of 179. Each trial links to its page on Pharma Observatory.

79 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.